Latest Financial Position News

Santana Minerals made significant strides in the June quarter at its Bendigo-Ophir Gold Project, progressing regulatory approvals, expanding mineralisation, and securing robust funding to underpin development plans.

ReNerve Limited delivered its strongest sales quarter ever with $211,000 in revenue, boosted by new distribution deals in Asia-Pacific and a $5 million funding facility to underpin growth.

New Age Exploration (ASX: NAE) has completed Phase 2 drilling at its Lammerlaw Gold-Antimony Project in New Zealand, revealing a new shear-hosted gold discovery at the Bella Prospect. Concurrently, the company has begun field exploration at its recently acquired Wallah Silver Project in NSW, setting the stage for maiden drilling.

Andean Silver has boosted its Cerro Bayo silver-gold project Indicated Resource by 230%, reaching 60 million ounces silver equivalent, underpinning its push toward feasibility and production restart.

Aurora Energy Metals progresses the Aurora Uranium Project with a major drill program imminent under Eagle Nuclear Energy, while broadening its Western Australian footprint with new exploration licences at Mukinbudin.

Odyssey Gold’s Stage 1 Scoping Study for Tuckanarra outlines a low-capital, near-term production of 79,000 ounces of gold, backed by a toll milling agreement at Kirkalocka and an updated resource base of 451,000 ounces.

Austin Metals has wrapped up a 4,216-metre RC drilling campaign at its Austin Gold Project, testing newly defined BIF-hosted gold targets at Brunswick Hill and Mt Sandy, with assay results still pending.

Osmond Resources has delivered robust assay results from drill hole SOR-08A and channel samples at its Orión EU Critical Minerals Project, underpinning a maiden Mineral Resource Estimate and a low-capex Scoping Study. The company is also progressing a secondary listing on the Bolsa de Madrid, supported by a fully assembled Spanish team.

PYC Therapeutics has made significant progress across its four RNA therapeutic programs, including dose escalation approvals in its Polycystic Kidney Disease trial and orphan drug designation for its Retinitis Pigmentosa candidate, supported by a robust cash position of $669 million.

Green360 Technologies has sealed its first binding supply contract with Holcim and ramped up MKX production, positioning itself as Australia’s leading supplier of low-carbon cement alternatives amid tightening SCM markets.

Nodestream has advanced its defence strategy with key leadership hires, a $6.5 million capital raise, and fresh product launches, while expanding its footprint in the US and European markets.

Axel REE has confirmed a breakthrough in sustainable rare earth extraction at its Woolrich deposit, surpassing previous test benchmarks and preparing for field trials in December 2026.